<SEC-DOCUMENT>0001178913-25-000658.txt : 20250303
<SEC-HEADER>0001178913-25-000658.hdr.sgml : 20250303
<ACCEPTANCE-DATETIME>20250303080011
ACCESSION NUMBER:		0001178913-25-000658
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250303
FILED AS OF DATE:		20250303
DATE AS OF CHANGE:		20250303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				813676773
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		25693823

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2532798.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><img width="624" height="15" src="image0.jpg"><br>
      <font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">UNITED STATES</font></div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND EXCHANGE COMMISSION</font><br>
      Washington, D.C. 20549</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">
      <div style="text-align: center; line-height: 1.25;">FORM 6-K</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br>
      UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">For the month of March 2025</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">Commission File Number 001-38807</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 16pt; font-family: 'Times New Roman',Times,serif; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">CHEMOMAB THERAPEUTICS LTD.</font><br>
      (Translation of registrant&#8217;s name into English)</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Kiryat Atidim, Building 7, Tel-Aviv, Israel</div>
    <div style="text-align: center; line-height: 1.25;">(Address of principal executive offices)</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">Form 20-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Form 40-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXPLANATORY NOTE</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On March 3, 2025, Chemomab Therapeutics Ltd. (the &#8220;Registrant&#8221;) issued a press release titled &#8220;Chemomab Therapeutics Announces Year End
      and Fourth Quarter 2024 Financial Results and Provides a Corporate Update&#8221;, a copy of which is furnished as Exhibit 99.1 herewith.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The financial information included in the consolidated balance sheets and consolidated statements of operations contained in the press
      release attached as Exhibit 99.1 to this Report on Form 6-K is hereby incorporated by reference into the Registrant&#8217;s Registration Statements on Form F-3 (File No. 333-275002 and 333-281750) and Form S-8 (File No. 333-259489 and No. 333-266868).</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">EXHIBIT INDEX</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb6f1a1d9ed3447a9a5fc0db3d2e537b4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 6.82%; vertical-align: top;">
            <div style="line-height: 1.25;"><u>Exhibit</u></div>
          </td>
          <td style="width: 93.18%; vertical-align: top;">
            <div style="line-height: 1.25;"><u>Description</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.82%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 93.18%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.82%; vertical-align: top;">
            <div style="line-height: 1.25;"><a href="exhibit_99-1.htm"><u>99.1</u></a></div>
          </td>
          <td style="width: 93.18%; vertical-align: top;">
            <div style="line-height: 1.25;"><a href="exhibit_99-1.htm"><u>Press release, dated
                  March 3, 2025, titled &#8220;Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update&#8221;</u></a></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <br>
    <div style="text-align: center; line-height: 1.25;">SIGNATURE</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
      signed on its behalf by the undersigned, thereunto duly authorized.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zd4b0c61bdbb24ee6bfa05fc277a53f2d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="vertical-align: top;" colspan="2">
            <div style="line-height: 1.25; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 46%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Date: March 3, 2025</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">By:</div>
          </td>
          <td nowrap="nowrap" style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">/s/ Sigal Fattal</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 46%; vertical-align: bottom;">
            <div style="line-height: 1.25;">Sigal Fattal</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 46%; vertical-align: top;">
            <div style="line-height: 1.25;">Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div style="line-height: 1.25;"><img width="624" height="15" src="image0.jpg"></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <div>
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
        <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
        </div>
        <div><br>
        </div>
        <img width="201" height="56" src="image00002.jpg"></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: normal; font-weight: bold;">Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: normal; font-weight: bold;">and Provides a Corporate Update</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">&#9472;Completed Successful FDA End-of-Phase 2 Meeting Following Positive Nebokitug Phase 2<br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">SPRING Trial Results in Primary Sclerosing Cholangitis (PSC)&#9472;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">&#9472;Achieved Alignment with FDA on Clear and Efficient Pathway to Potential Regulatory Approval <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">for the Treatment of PSC with No Liver Biopsies or Confirmatory Studies Needed; Nebokitug <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Positioned to Potentially Become the First FDA-Approved Treatment for PSC&#9472;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">&#9472;On Track for Releasing Clinical Data from SPRING Trial Open Label Extension in First Quarter 2025-</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">-Discussions with Potential Strategic Partners Ongoing&#9472;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">TEL AVIV, Israel, March 3, 2025 </font>-- <u>Chemomab Therapeutics Ltd</u>. (Nasdaq: CMMB), a clinical stage biotechnology company developing innovative therapeutics for
      fibro-inflammatory diseases with high unmet need, today announced financial and operating results for the full year and fourth quarter ended December 31, 2024, and provided a corporate update.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">&#8220;The past year has been a transformative period for both Chemomab and the PSC field,&#8221; said Adi Mor, PhD, co-founder and Chief Executive Officer of Chemomab. &#8220;Following rapid enrollment in our nebokitug (CM-101) Phase 2
      SPRING trial in patients with PSC, we were able to report topline results in July, approximately six months ahead of schedule. We and our PSC expert advisers view these Phase 2 data as the strongest in PSC to date. Nebokitug achieved the SPRING trial
      primary endpoint, demonstrating a favorable safety profile. Additionally, patients treated with nebokitug who had moderate/advanced disease showed improvements in multiple secondary efficacy endpoints encompassing the fibrotic, inflammatory and
      cholestatic aspects of PSC. This is the first time that an investigational drug for PSC has shown improvements across such a wide range of highly relevant disease markers. These promising results set the stage for our FDA End-of-Phase 2 meeting. We
      recently reported the <u>positive results</u> of that meeting and outlined the design for a single pivotal Phase 3 trial for nebokitug in PSC, which provides us with a clear and streamlined pathway to potential regulatory approval.&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Dr. Mor continued, &#8220;We were very pleased by FDA&#8217;s positive and collaborative spirit at the meeting and their stated commitment to facilitating the advancement of effective new therapies for PSC. We aligned on a full
      regulatory approval&#160; program for nebokitug using a single pivotal Phase 3 trial based on well-characterized clinical events that are associated with disease progression in PSC. Neither liver biopsies nor additional confirmatory studies will be
      needed. The design is similar to the approach used in oncology trials and is both feasible and efficient. Importantly, use of a clinical event-driven endpoint helps derisk the Phase 3 trial, since key publications have linked the type of improvements
      in PSC biomarkers seen in nebokitug-treated patients in the SPRING trial with decreases in clinical events.&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Dr. Mor added, &#8220;We continue to assess a variety of potential strategic paths forward. The recent positive developments have been of keen interest to potential strategic partners and active discussions are advancing
      following FDA&#8217;s regulatory guidance. At the same time, we are laying the foundation for beginning the Phase 3 trial, leveraging the strong relationships our clinical team developed with global PSC centers during the SPRING study. We believe that
      nebokitug could become the first FDA-approved therapy for PSC, addressing the tremendous unmet need in this devastating, often lethal disease. We look forward to reporting data from the SPRING trial Open Label Extension later this quarter.&#8221;</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">2024 and Recent Highlights:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zfec66ab736d14097b7f83ddc8d7d26c8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On February 19, 2025, Chemomab reported that the International Nonproprietary Names (INN) program of the World Health Organization had assigned the INN designation nebokitug to the company&#8217;s lead product candidate CM-101.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z9f15b303cf1d45bfa3dc02188b2305a6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On February 19, 2025, Chemomab announced the successful completion of its End-of-Phase 2 Meeting with the U.S. Food and Drug Administration (FDA) and alignment with FDA on the design of a Phase 3 registration study for nebokitug for the
              treatment of PSC. The design provides clarity on a streamlined path to full regulatory approval based on a single pivotal trial that does not require liver biopsies or confirmatory studies. The primary endpoint measures time-to-first clinical
              event and encompasses multiple clinical events associated with disease progression. Key publications have shown that the reductions in PSC biomarkers seen in the nebokitug Phase 2 SPRING trial are associated with reductions in clinical
              events, increasing&#160; confidence in the relevance of this approach for the nebokitug Phase 3 trial. The company is sharing the Phase 3 design in active discussions with potential strategic partners while laying the groundwork for initiating the
              Phase 3 program.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z517613e4129246febb04bf9b54cef25d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">On January 13, 2025, a new peer-reviewed publication in the journal <font style="font-style: italic;">Cells</font> further confirmed the key role of the soluble protein CCL24 in driving the fibro-inflammatory pathologies underlying PSC, systemic sclerosis and other fibrotic diseases<font style="font-style: italic;">.</font> The review describes the pivotal role CCL24 plays in initiating and advancing fibrotic processes, highlighting its impact on fibrotic,
                  immune and vascular pathways. It also presented preclinical and clinical evidence supporting the therapeutic potential of blocking CCL24 with agents like nebokitug in diseases that involve excessive inflammation and fibrosis.</div>
              </div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" id="z3f92fe4de3d44b56a709b7d909a72705" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div>On November 19, 2024, Chemomab reported that data from its Phase 2 SPRING trial in patients with PSC was presented at the&#160;American Association for the Study of Liver Disease (AASLD)&#160;The Liver Meeting&#174; 2024. In an oral, late-breaking
                presentation, Professor&#160;Christopher Bowlus, MD, a SPRING trial investigator and&#160; Professor and Chief of the Division of Gastroenterology and Hepatology at the University of California Davis School of Medicine, discussed data from the
                double-blinded, placebo-controlled portion of the Phase 2 trial.<br>
              </div>
            </td>
          </tr>

      </table>
      <br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zd9b72fd6afa5498c85fd4e26de693a00" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On July 30, 2024, Chemomab announced the closing of a private placement that resulted in gross proceeds of approximately&#160;$10 million to the company. Existing investors such as OrbiMed and new investors including HBM Partners and Sphera
              Biotech Master Fund&#160;participated in the financing.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z881bd9ae641f41e395944131481ab9d9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On July 25, 2024, Chemomab reported positive topline results from the nebokitug Phase 2 SPRING trial in patients with PSC. Nebokitug met the primary study endpoint, demonstrating a favorable safety profile and nebokitug-treated patients
              with moderate/advanced disease showed improvements on a wide range of disease-related secondary endpoints, including liver stiffness, liver fibrosis biomarkers, such as the Enhanced Liver Fibrosis (ELF) score and PRO-C3 levels; total
              bilirubin and liver function tests; pruritus (itch) and markers of inflammation. Dose-dependent responses were observed for multiple disease-related biomarkers. A consistent pattern of greater improvement on the secondary endpoints was
              observed in the study arm receiving the 20mg/kg dose of nebokitug. This dose has been selected for the active treatment arm of the Phase 3 trial.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z47912edaed5044ff9b50382833046ba2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On June 18, 2024, Chemomab announced new scientific publications had been published in the peer-reviewed journals&#160;<font style="font-style: italic;">International Journal of Molecular Science</font> and <font style="font-style: italic;">Drug

                Safety</font> that reinforced the clinical potential of nebokitug in PSC.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="za2395d6ff68a4113b4c645a0dac3ec74" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On June 6, 2024, Chemomab presented new scientific and clinical data at EASL 2024 and at a Gordon Research Conference supporting the clinical potential of nebokitug as a novel treatment for PSC. The findings helped elucidate nebokitug&#8217;s
              mode of action in liver fibrosis and could help in characterizing its anti-fibrotic drug effects.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zf27f72eb3c0647f68781e8e3da340ecd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On April 18, 2024, Chemomab announced the publication of a new study in the journal <font style="font-style: italic;">Arthritis Care and Research </font>that confirms the key role of CCL24 in systemic sclerosis. The longitudinal study of
              more than 200 SSc patients showed that elevated levels of serum CCL24&#160; are associated with increased mortality and disease severity across the fibrotic and vascular manifestations of the disease.</div>
            <div> <br>
            </div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zdc663505ebc7470092815a63dd89b1b0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On April 10, 2024, Chemomab hosted an expert PSC webinar featuring Christopher Bowlus, MD, of UC Davis Health; Ricky Safer, founder and CEO of PSC Partners Seeking a Cure and Massimo Pinzani, MD, PhD, of the UCL Institute for Liver and
              Digestive Health and UPMC ISMETT.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zfa55db09085b4728b419942c9f8a9046" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>In March, 2024, Chemomab reported that the European Patent Office had granted a new patent for nebokitug, covering the use of nebokitug and sequence-related anti-CCL24 antibodies for the treatment of liver diseases, such as PSC. In
              February, new patents were granted in Brazil and Israel.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="ze6a5919211cf4f5db52335e2c3eb2e96" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On January 30, 2024, Chemomab reported publication of new proteomics research in the peer-reviewed journal <font style="font-style: italic;">Cells</font>. The proteomic analyses of human samples highlighted the unique role of CCL24 in
              activating key PSC-related disease mechanisms and further confirmed the potential of nebokitug as a promising treatment for PSC.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zafd80ff4f578407d9670a1dfffe54483" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>On January 3, 2024, Chemomab announced early completion of patient enrollment in the nebokitug Phase 2 PSC SPRING trial and moved up the expected topline data readout to midyear 2024.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Full Year and Fourth Quarter 2024 Financial Highlights:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zb3cf29180e6e4ab4a2eb2a56b5708bf6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div><font style="font-weight: bold;">Cash Position:&#160;</font>Cash, cash equivalents and short-term bank deposits were $14.3 million as of December 31, 2024 compared to $19.9 million as of December 31, 2023. The current cash runway is expected to
              take the Company through the first quarter of 2026.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zdcca2d180261490196b41c2729c926d7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div><font style="font-weight: bold;">Research and Development (R&amp;D) Expenses:&#160;</font>R&amp;D expenses were $2.4 million for the fourth quarter and $ 11.3 million for the full year ended December 31, 2024, compared to $3.1 million and $18.4
              million for the respective periods in 2023.&#160;The decrease in R&amp;D expenses in the fourth quarter of 2024 compared to the fourth quarter of 2023 primarily resulted from decreased clinical costs as the company&#8217;s nebokitug Phase 2 PSC trial
              was nearing completion.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb0dd0b4da2ba47199ddde31e69e3037e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div><font style="font-weight: bold;">General and Administrative (G&amp;A) Expenses</font>:&#160;G&amp;A expenses were $0.8 million for the fourth quarter and $3.4 million for the full year ended December 31, 2024, compared to $0.8 million and $7.1
              million for the fourth quarter and full year in 2023.&#160;The decrease in G&amp;A expenses reflected selected reductions in headcount and reductions in share-based payments and recruitment costs.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z09a2984c2c1c4122877fec497da9c7d3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div><font style="font-weight: bold;">Net Loss</font>:&#160;Net loss was $3.0 million, or a net loss of less than $0.01 per basic and diluted Ordinary Share, for the fourth quarter and $13.9 million, or a net loss of $0.04 per basic and diluted
              Ordinary Share, for the full year ended December 31, 2024, compared to a net loss of $3.4 million, or a net loss of $0.01 per basic and diluted share, for the fourth quarter of 2023, and $24.2 million, or a net loss of $0.10 per basic and
              diluted Ordinary Share, for the full year ended December 31, 2023.&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">The weighted average number of Ordinary Shares outstanding, basic and diluted was 324,649,751 (equal to 16,232,489 ADSs) for the year ended December 31, 2024, and 234,998,859 (equal to 11,749,943 ADSs) for the year ended
      December 31, 2023, respectively.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">For further details on the company&#8217;s financial results for the year ended December 31, 2024, please refer to the company&#8217;s annual report on Form 20-F, which will be filed with the SEC in March, 2025.</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Forward-Looking Statements</div>
    <div style="line-height: 1.25;">This press release contains forward-looking statements within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All
      statements other than statements of historical facts contained in this press release, including statements regarding our future financial condition, results of operations, business strategy and plans, and objectives of management for future
      operations, as well as statements regarding industry trends, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potentially,&#8221; &#8220;will&#8221; or the negative
      of these terms or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations,
      business strategy and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, among other things: the risk that certain acknowledgements from the End-of-Phase 2 (EOP2) meeting with
      the FDA in connection with PSC regulatory approval will not materialize into a pathway for regulatory approval; that certain conclusions and assumptions drawn from the EOP2 meeting with the FDA discussed in the press release will prove incorrect and
      adversely affect the ability for nebokitug to become an FDA fully approved therapy; the risk that the full data set from the nebokitug study or data generated in further clinical trials of nebokitug will not be consistent with the topline results of
      the nebokitug Phase 2 PSC trial; failure to obtain, or delays in obtaining, regulatory approvals for nebokitug in the U.S., Europe or other territories; failure to successfully commercialize nebokitug, if approved by applicable regulatory
      authorities, in the U.S., Europe or other territories, or to maintain U.S., European or other territory regulatory approval for nebokitug if approved; uncertainties in the degree of market acceptance of nebokitug by physicians, patients, third-party
      payors and others in the healthcare community; nebokitug development of unexpected safety or efficacy concerns related to nebokitug; failure to successfully conduct future clinical trials for nebokitug, including due to the Company's potential
      inability to enroll or retain sufficient patients to conduct and complete the trials or generate data necessary for regulatory approval, among other things; risks that the Company's clinical studies will be delayed or that serious side effects will
      be identified during drug development; failure of third parties on which the Company is dependent to manufacture sufficient quantities of nebokitug for commercial or clinical needs, to conduct the Company's clinical trials; changes in laws and
      regulations applicable to the Company's business and failure to comply with such laws and regulations; business or economic disruptions due to catastrophes or other events, including natural disasters or public health crises; and uncertainties with
      respect to the Company's need and ability to access future capital; and the intensity and duration of the current war in Israel, and its impact on our operations in Israel. These risks are not exhaustive. You should carefully consider the risks and
      uncertainties described in the &#8220;Risk Factors&#8221; sections of our 20-F for the year ended December 31, 2023. New risk factors emerge from time to time, and it is not possible for our management to predict all risk factors, nor can we assess the impact of
      all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in, or implied by, any forward-looking statements. You should not rely upon forward-looking
      statements as predictions of future events. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release. Before you invest, you should read the documents
      we have filed and will file with the SEC for more complete information about us. You may get these documents for free by visiting EDGAR on the SEC website at <u>www.sec.gov</u>. This press release shall not constitute an offer to sell or the
      solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities
      law of any such state or jurisdiction.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">About Chemomab Therapeutics Ltd.</div>
    <div style="line-height: 1.25;">Chemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique role of the soluble protein CCL24 in promoting fibrosis and
      inflammation, Chemomab developed nebokitug (CM-101), a first-in-class dual activity monoclonal antibody that neutralizes CCL24 and has demonstrated disease-modifying potential. In clinical and preclinical studies, nebokitug has been shown to have a
      favorable safety profile and has been generally well-tolerated, with the potential to treat multiple severe and life-threatening fibro-inflammatory diseases. Chemomab has reported positive results from four clinical trials of nebokitug in patients.
      Based on recent positive data from its Phase 2 SPRING trial in primary sclerosing cholangitis (PSC), the company is preparing for potential initiation of a PSC nebokitug Phase 3 trial. The design calls for a single pivotal study based on a clinical
      event primary endpoint that provides a clear and streamlined pathway to potential regulatory approval. Data from the SPRING trial open label extension will be reported in the first quarter of 2025. Nebokitug has received FDA and EMA Orphan Drug and
      FDA Fast Track designations for the treatment of PSC. Chemomab&#8217;s nebokitug program for the treatment of systemic sclerosis has an open U.S. IND. For more information, visit: <u>chemomab.com</u>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Contacts:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Media and Investors:</div>
    <div style="line-height: 1.25;">Barbara Lindheim</div>
    <div style="line-height: 1.25;">Consulting Vice President, Investor &amp; Public Relations, Strategic Communications</div>
    <div style="line-height: 1.25;">Phone: +1 917-355-9234</div>
    <div style="line-height: 1.25;"><u>barbara.lindheim@chemomab.com</u></div>
    <div style="line-height: 1.25;"><u>IR@chemomab.com</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: right; line-height: 1.25;">Chemomab Therapeutics Ltd. and its subsidiaries</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-weight: bold;">Consolidated Balance Sheets as of</div>
      <div style="line-height: 1.25; font-weight: bold;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
    <div style="line-height: 1.25;">In USD thousands (except share and per share amounts)</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z8ef3bbcc24c748fea6a8d1721e70ce6d" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"> 2024</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">2023</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25;">Cash and cash equivalents</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">6,071</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">9,292</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Short-term bank deposit</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">8,195</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">10,492</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25;">Restricted cash</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">76</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">76</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Other receivables and prepaid expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">1,698</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">1,037</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Total current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">16,040</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">20,897</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Non-current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25;">Long-term prepaid expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">385</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">559</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Property and equipment, net</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">250</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">303</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">Operating lease right-of-use assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">289</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">392</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-weight: bold;">Total non-current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">924</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">1,254</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
              <div style="line-height: 1.25; font-weight: bold;">Total assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">16,964</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">22,151</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25; font-weight: bold;">Current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Trade payables</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">666</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">516</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25;">Accrued expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">1,563</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">3,423</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Employee and related expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">874</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">823</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">Operating lease liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">115</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">76</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-weight: bold;">Total current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">3,218</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">4,838</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Non-current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">Non-current<font style="font-weight: bold;">&#160;</font>operating lease liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">209</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">316</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Total non-current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">209</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">316</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25; font-weight: bold;">Commitments and contingent liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
              <div style="line-height: 1.25; font-weight: bold;">Total liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">3,427</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">5,154</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="line-height: 1.25; font-weight: bold;">Shareholders' equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Ordinary Shares no par value - Authorized: 4,650,000,000 and 650,000,000 Ordinary shares as of December 31, 2024, and&#160; December 31, 2023 , respectively</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="line-height: 1.25;">Issued and outstanding: 377,132,220, and 284,094,700 Ordinary shares as of&#160; December 31, 2024 and 2023, respectively</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;"><font style="font-weight: bold;"></font>-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Additional paid-in capital</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">116,160</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">105,675</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25;">Accumulated deficit</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">(102,623</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">)</div>
              </div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(88,678</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-weight: bold;">Total shareholders&#8217; equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">13,537</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">16,997</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
              <div style="line-height: 1.25; font-weight: bold;">Total liabilities and shareholders&#8217; equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">16,964</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">22,151</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">(*) 1 American Depositary Share (ADS) represents 20 Ordinary Shares</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: right; line-height: 1.25;">Chemomab Therapeutics Ltd. and its subsidiaries</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-weight: bold;">Consolidated Statements of Operations</div>
      <div style="line-height: 1.25; font-weight: bold;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
    <div style="line-height: 1.25;">In USD thousands (except share and per share amounts)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z568662c96f7640ca865e7e553207a8e1" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Three months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Three months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Year Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">December</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;"> December</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="2" class="cftcurrcell" rowspan="1">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="2" class="cftcurrcell" rowspan="1">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2024</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">2023</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2" class="cftcurrcell" rowspan="1">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">2024</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2" class="cftcurrcell" rowspan="1">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-align: center;">2023</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">Audited</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Operating expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Research and development</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">2,411</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">3,097</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">11,327</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">18,381</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">General and administrative</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">802</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">751</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">3,412</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">7,078</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Total operating expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">3,213</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">3,848</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-weight: bold;">14,739</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">25,459</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Financing income, net</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">(250</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">)</div>
              </div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(431</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">(794</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">)</div>
              </div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(1,238</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-left: 23%; width: 52%;" colspan="1">
              <div style="text-align: right; line-height: 1.25;">`</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">Net loss for the year</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">2,963</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">3,417</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-weight: bold;">13,945</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">24,221</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z34ddd3d1224a4ba69976781e52d94b05" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%;" rowspan="1" class="cftdesccell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" rowspan="1" class="cftdesccell">
            <div style="line-height: 1.25;">Basic and diluted loss per Ordinary Share</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-weight: bold;">0.008</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;">0.013</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-weight: bold;">0.043</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;">0.103</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z9412b5bc32c24728956aa1b54b443cde" class="cfttable">

        <tr>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 52%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" class="cftdesccell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 9%; text-align: right;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; white-space: nowrap; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 9%; text-align: right;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; white-space: nowrap; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 9%; text-align: right;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; white-space: nowrap; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; width: 9%; text-align: right;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
          <td style="background-color: rgb(255, 255, 255); vertical-align: bottom; white-space: nowrap; width: 1%; padding-top: 0px; padding-right: 0px; padding-left: 0px;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" class="cftdesccell">
            <div style="line-height: 1.25;">Weighted average number of Ordinary Shares outstanding, basic, and diluted</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-weight: bold;">377,132,220</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;">260,274,470</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-weight: bold;">324,649,751</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              <div style="line-height: 1.25;">234,998,859</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">(*) 1 American Depositary Share (ADS) represents 20 Ordinary Shares</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0X!W\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ V #8  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #M T8# 2(  A$! Q$!_\0
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MG>,E*/*Y*"A-N#:/]:JBBBOX?/W4**** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>&?$VG6A#QQ:K<WEA:^&M0DA-O\ ;=+U&.2]:Y?1M,CA_)^OO[_@F%\.-?\
MB+^VK\&CH]I/)8>!]8NOB%XFU"- T&DZ+X8L;BXBFNV8C:FHZW+H^@P[ [_:
MM6@;:(DEEC[_ !MR_(LS\(_$7#\1T\-/*Z?"&>XN4L5RJ.'QF"R^OBLMQ5&4
MOAQF&S"EAJN"Y4YRQ4:4(1FY<DL\@J5Z6=99+#.:JO&X>'N7O*G4JQA5A*WV
M)4G-3OHH-MVM=?VE4445_@"?T2%?Y<O_  <3_M_>-OVP/V_OBG\*;+Q+J+?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?!O_  48_9<N?VJ?V<-<\,>';=)OB+X+O8_'?P[4E$?4-:TJTN[:^\-F9WB5
M$\2Z-=WVG6XFECM(]9_L>]NCY5EE?O*BOH>%.)\VX,XER3BO(ZRH9MD&98;,
ML%.:<J4JN'J*3H5X*474PV)I\^'Q5+FBJN'JU:;:4V<^+PM''86OA,1'FHXB
ME.E42T?+)6YHO6TXNTH2^S))]#_/ O+.[TZ[NM/U"UN;&_L;F>SO;*\@EMKN
MSN[:5H;FUNK:94FM[FWF1XIX)426*5&CD574@5J_K=_;O_X):^#?VGM0U#XH
M_"[4],^''QIGA+ZL;NVD'@OXA3Q1%()/$B6$,M[HNO';%&WBC3K74&N8$,>J
MZ/J,[0W]G_.Q\4_V$_VMO@_J4]CXM^!/C^[M8YYXH=?\(:'=^./#5U'#*8XK
MA-;\)QZO9V:7BXGM+;56T[47B)\VQAEBGBB_VR\*/I'>&WBEE.#JT,\R[A_B
M25*"S'A;.L?A\'C\/BE%>V67SQ,J%/.,'S)SHXK!<\O8N'UNAA*[G0A^$YQP
MQFF4UIIX>KB<+S/V6+H4Y3IRA?W?:J',Z$]DX5++FOR2G&TG\DT5Z[HO[/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR:?J^C6]]X[\>RV4T%YIO@+P_=74"20V]Q:ZMXLU/_B0Z%/;"/6=;T#^9/\
M:'_:Q_;B_P""E_Q>?5_BQXQ^*G[0'C;5;Z[U#PO\,_">F:YK'AWPO JR#[!\
M/?A7X5MKC2]"LK"SE^S23Z7I#:G>19NM<U+4M0GNKV?6?A=FO%_%?%V:U\71
MR7(Z?$>=1_M'%4W4EB)4\?755X6@ZE",Z5*2<*N(J5Z5*-12A!U9TZL:9_K5
MA,FRG)L+"E/'8^>5X!_5:,E'V:EA:+C[:IRU'"4T[PA&G.;C[TE&,H.7^I#=
M?\%;/^"8-GJ*:7+^W]^R0]S(2%EM?CM\/;[3AAY(_GU>RUVXTF+YHF(,MZ@*
M&.4?NYH7?Z[^$WQR^"WQ[\-1>,O@=\7?AE\8_"4SRQ1^)OA=X[\,>/M",T$T
MEM<0-JOA;5-4LDN+:YAFMKFW>99[>YAFMYXXYHI$7_'<\9?L4?ME_#GP[J?B
M_P"(7[)'[3?@3PGHMK/?:SXH\9? 7XJ>%_#NDV-K$T]S>:GK>M^%+'3;"UMX
M4>:>XNKF*&*)&DD=54D>:_!WXV_%_P#9[\>Z/\4/@=\2O&OPH^(6A2(VF^+?
M ?B'4O#FLQPK<VUW+I]S<:=/ -1T>\FM+?\ M/1-16[T?588A;:G8W=L6A;W
MJW@+E6+PM2>1\6.OB(.R=:CAL3A92Y6U2J3P=:,Z#D^5^T2K.,4_W,VU;S8>
M(&+HU8K'Y1[.E)7]R=6E52NO?C&M3<:B6ONW@F[>_&SO_M?T5_,%_P $$?\
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MA*>7X+$K!SJ8['*I*GE]*MS^SC#$UL-&53$>Q7\5T6X0C0E-MV<5&TY?Z?\
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MU 45^;?_  4D_P""I?[,7_!,7X7VOC7XWZW-K?COQ5%?1_"[X+>%IK:;Q_\
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MN[;7]2U:.\T'P_J&CWFGW^KV'^BS\*?A!\+/@5X'T7X:?!GX>>#OA=\/_#L
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M#!#&\LLCD*D:,S$ &O\ (J_X*V_M^^)?^"C'[:_Q2^.$VJWTOPLTG5+KP%\
M?#D_VB&S\._"'PU=SVOA^[AT^ZL[&[L]6\;S"Z\>^)H]0@?4+;7/$=UI!G.F
M:1I5K:?Z.W_!='X[7W[/'_!*7]LCQOI%Q<6VO>(?AO;_  CT2:RNVL;^"[^-
M?B31/A5>7UC=1S03PW>D:+XMU76HI+:07$?]FM)$-R9'^6C^RU\$-2_:6_:5
M^ 7[/>E-?PW?QJ^,/PZ^&+7NF6K7EWI-EXS\5Z5H6J:\(1%,BV_A_3+V\UN^
MN9XS:6=C87%Y>LEI!,ZZ> ^3X3#X7/\ C#&P7^Q*>7X:M))K#TJ.'CC<SJQ3
MNU4E2GA8*I'EE&G[>FI.-::4\?XVM4J9=DU"3OB&J]6";7M93J>PPL)6WBJB
MK2<7=.:IRLG33/Z[O^#:K_@BIX/\>:!X?_X*+_M8>#8?$>EOJMQ-^RW\*_%.
MG"70KJ30K\6\GQT\3:3=$QZRL.KVEYIWPSTG5;1]+22QNO'IM=0DD\$:I8?W
M4 !0%4     #  '   X  X '2N3\ ^!O"GPP\#>#?AMX$T2P\->"/A_X6T#P
M5X0\.Z5;066F:%X8\+Z5:Z)H6D6%I;1PV]M9Z=IEE;6EO!!%'%'%$J(BJ !U
MM?BG%W%.8<79WBLVQU2?).<H8'"N5Z>!P49/V&&I17NIQC:5:<4G6K2J59>]
M,^XR?*L/D^!I8/#PC>,8RKU4O>KUW%*I5DWJ[O2$6[0@HPC9(****^8/4.3\
M=^!/!7Q0\&^)?AY\1O"GA_QSX$\9:/>^'O%GA#Q5I-EKGAWQ%H>I0M!?:7K&
MDZC#<65]97,3%9(;B%U/# !U5A_F&?\ !=__ ((]7'_!,CXUZ3XU^$QU36/V
M2?C?JFIO\,;G5+BYU/5_AEXIMHCJ.K?"+Q'K%QOGU6*RLS)J?@/7=0EDU;6_
M"\%S9:Q/JFN^&M9UW5O]1^ORV_X+/_LFZ9^V1_P3;_:>^%[:--J_C/PS\/\
M5_C!\*!8)I_]L1?$[X36-UXR\-V&D7&IPRVMI-XNBTW4/ .I2DVTDF@^+-7M
MHKZPEG2]M_T/PUXRQG"7$6#_ -H<<HS'$T,+F^&G*U!T:LU2CC+2?+"M@G/V
MT:JY9.G&I1E+V=62/G.)LEHYQEU9>SOC,-2J5<'5BOWBJ1CS>QNM90K\O)*+
MNE)QFES1B?Y'%?[%W_!,;_E&Q_P3U_[,=_9-_P#5"^ :_P =&O\ 8N_X)C?\
MHV/^">O_ &8[^R;_ .J%\ U^T?2$_P"1-P]_V,\5_P"HJ/B/#G_?<R_[!:7_
M *=9]Q5_F1?\'37_ "EF\8_]D0^"W_ICOZ_TW:_S(O\ @Z:_Y2S>,?\ LB'P
M6_\ 3'?U^<>!?_)<K_L3YA_Z5ACZ?CS_ )$$_P#L+PWYS/P!TSQ#\0-;\/Z=
M\(M%U3Q1JOAO5O&MMXATSX=:3-J-YI^L_$#4+*'PQINJ6_AJR\Q-6\426$@T
M+1YOLMSJ,,%_=V&F^6-4O8[K_0-_X(V?\&W7P@^ O@;PK^T!^WWX%T'XM_M%
M^(+:T\0:3\%O$\-EX@^%WP1L[B.*YT[2O$&B2)<:1\0/B7;J?-\17FIG4?!_
MAW4&&C>&]/U.XT<^,];_  C_ .#6?]C31OVCOV^=:^./C72K35_!'[(7@VS\
M?6%G=O'+%-\7_&=_=:#\+Y+G3Y;>5+JVT:QTSQUXMM;D30R:=XE\,^&[A!+E
M@G^E57V/C1QYC<#C9\(9)5> @J5/%9WB<*_8XBO6Q<57IX-5*;C*G3E0E2Q&
M*FFJF)]M"E*2HQJQK^+P1D%"O0CG..C]8FYRI8&G5]^G3A1?LW6Y974IJ<94
MZ47[M)0<DG.473HZ;IFFZ+I]GI.CZ?8Z3I6G6\5II^F:;:06&GV-I H2&UL[
M.UCBMK6WA0!(H8(TCC4!44 8IFKZ/I'B#3+[1=>TK3M;T;4[=[34M)U>QMM2
MTS4+648DMKZPO8IK6[MY!P\,\4D;C[RFM&BOYKN[WN[WO?K?O?N?II_'9_P6
MA_X-M/A1X[\">-/VFO\ @GGX$M/AM\6O"VFS^(O%?[-O@ZQ@L_AY\3],T](F
MU%OAAX=A:"S\ ^-[/3(KB\M/#.@1Q^%?%<EG'IFFZ#I'B&_?4=3_ (/_ (7?
M%#X@_!3XB^#/BU\*?%FL>!?B/\//$.F^*O!OB[09Q;ZIH6NZ5.MQ9WD!D26W
MGC+*8;RPO8+G3M2LI;C3]1M+NPNKBVE_VTZ_R_/^#E3]BS2_V2O^"C?B7QAX
M)T)=%^%_[4WAR#XX^'K:SMHK;2--\<7FH7>B_%C0K$1/S,_BNR7QS=1>3##:
M1>/[*TMPT4 V_P!-^#/'>+S:KB.#N(*SS&%3"5:F5UL;+V]2=&E"V+RNNZO.
M\52>'<JU!5.9TZ-'$49.=)T84OR[C;(*.$A#.\N@L-*G6A'%0H1]G%2E)>QQ
M5/DY52J*KRPJ.-N>=2G-<M13=3_0$_X)A_MR>&_^"A_[&'PD_:5TA-/T[Q/K
MFG2^&OBMX7T^7S(O!_Q7\+&/3_&6BI&\DEQ;Z?=7/D>(_#B7;?:IO"NNZ'=S
M?/<&BOY&O^#0[]JF+P;\2_VLOV7O%GB*6S\+>*? WAKX]^%+*\ &D:5K_@[7
M]-^'GC>Z@F1/,CU+Q-IWC?P#%-%(9$GM?",#1"$VTWGE?BO'O#BX7XKS;**$
M9O!TZT<1@6U-_P"QXNG#$T*?-)7F\.JCPTY_:J49N[/N,@S)YKE.#QL[>VG!
MTZZ5OX]&3I5)<JTBJDH^UC'=0J1\C^HG_@I]^P9=?M4^#-.^(OPRM;,?'#X=
MZ;<6ME8RF&V'Q!\(*]S?R>$'OI#'';ZSI]]/<:AX3N+R5=/^U7NJZ5>M;1ZP
MFJ:7_)%JVDZKH.IZAHFN:9J&BZSI-Y<:=JND:M97.G:GIFH6<K07=CJ%A>1P
MW=E>6LZ/#<6MS%'/!*C1RHKJ0/\ 0XKX]_:4_83_ &;OVJ=^H?$SP6;3QDMF
M;*T^(O@^Z'AWQK;1",1P"YOHX+G3?$$=FJ@6%OXITK7;6Q7>MG! LLH?^J?H
MY?2TJ>&&64."..L%CLXX0P]2;R?,<O\ 9U<VX?C7J2JU<)+#5ZE&&8Y4Z]25
M>G!5Z6+P'/7C06,I2H82A\[Q-P<LVJRQ^ J4Z&-DDJU.K=4<3RI*,^:*DZ59
M12BWRRA4M'FY)*4Y?P\T5_1KXJ_X(,Z3-?R3>"/VDM1T[2V($6G>*OAI;:S?
MPKF0EY-9TCQCH-O<G'E((UT&U&1)(93N6)?1?AG_ ,$+_@WH-Y:7OQ4^+_C?
MXBK;3I/+I'AO1=-^'FD7J*VXV5\\E_XPUE[9Q\DLNG:MI-VZ@M#-:L1M_M/%
M?3(^C_A\O^NTN+<=CJ_)SQRO"\,\1QS"4DKNES8S+<)ET9W]WFJ8^%)MWC5<
M4Y+X:'!/$4JG(\'3IQO;VT\5AG3];0JSJVZZ4F_*^A^ _P"S9^S/\4OVIOB+
M8?#SX8Z++=/YEK<>)O$ES'(GA[P9H<UP(9M<\07P 2&)%$IL["-FU'5IXFM-
M-M[B;<$_M8_9X^ ?@3]FGX3^&/A+\/K0QZ3H-L)-1U6XCC75/$_B"Y2,ZQXF
MUF2/B34=5N4\QHU/V>QM4M=,L4AL+*UACZ3X5?![X8_ _P )VO@?X3^"M#\#
M^&+1A)_9^C6Q1[RZ\M(FO]6U"=Y]2UG4Y8XXTGU/5KN]U"=402W+A5 ]*K_.
MSZ0_TD,X\;,;ALLP.$KY#P1E.(EB,ORBK653&9EC.5TH9IG4J+>'>(ITI3A@
M\'1=6C@(UJZ6(Q52K*L?I?#?#-'(:<JLYQQ&/K14:M=1:A3A=/V-!/WN3F2<
MYRM*HU%N,$E%%%%%?S(?4A7F7Q;^#?PR^.O@W4/ /Q7\':/XS\,:BDF;35+<
M&YTZZ>*2%-3T/4XC'J6A:Q;I(XM=6TFZL]0M]S"*X57=6]-HKJP..QN68S#9
MAEN+Q6 Q^#K0Q&$QN"KU<+B\+B*4E*G7P^(HRA5HU:<DI0J4YQG%JZ:)G"%6
M$J=2$:E.:<9PG%3A.+T<91DG&2:T:::9_&]^W]_P3Q\6?L>ZY#XJ\-76H^,_
M@;XCU VFA>*;J"+^U_"^I3&:6W\+^,A:1QVQO'MXV.EZ];6]GI^MB&919Z=>
MQFQ/P-X!\<^)_AEXU\+?$+P7J<VC>*O!NNZ=XAT'482<V^H:9<I<PB:/(6YM
M)]AM[ZRFW6]]92W%G<QR6\\L;?WQ_$GX=>#OBYX$\4?#;Q_HT&O^#_&.DW.C
M:YI=P63SK6X *3VUQ&5GLM1L;A(;[3-1M7BO--U"VMKZSFAN;>*1?XO/VTOV
M+OB'^Q[\1;G0]:MK_7/AOK=Y</\ #OXBBTV:?X@T\#SUTW47@+V^G>*=,B/E
M:II4C1--Y1U+3XY-,N(91_K?]%_Z1>&\6,HK>'_B#B,%5XTPV$JT*53%TZ%.
MAQIDTJ,J>(YJ#4</5S;#T7.&9X.%.*QF$:QU&C.,<P6&_'.*^&IY/6CF66QG
M' RG&4E!R<L#74DXM2^*-&4K.E-O]W/]VVKTN;^K3]C']LSX=?MA_#>W\1^'
M;BVT7Q_HEM:6_P 1?AY-<J=4\-:L\81[VRC=_/U+PIJDZR2Z%K<:E)8]UA?B
MUUBSO[&W]S^,'P-^#/[0?@VZ^'GQU^%7P]^,'@:]EAN;CPG\2?"&A>,M"-W;
MNLMK?1:=K]C?6]MJ%I,B36>H6R17MI,B36T\4J*X_@^^'_Q%\=?"KQ5IGCCX
M<>*M;\&>+-'D,FGZYH-[+97D2L1YMO*4/E7=C<JHCO-/O([BQO8=T%W;S0LR
M']G_ (.?\%R?BQX:TVRTCXT_"OPW\39+?R8)/%7AC5W\!:]<6ZQHLMYJ>E_V
M7K_A_4=2>022L-*MO"U@ZLD2VT!1II/P;Q;^A)Q?E6=8K._"&='.<EKXB6*P
MW#^(S*CEN>Y+.4O:?5\'C<PK8?!9A@Z#N\+7JX[#YA"G[.A4I8NK3EBZWT&3
M\=8&OAXX?.TZ-90Y)XA4I5<-B%:UZE.G&<Z<YKXXJG*DW>2E"+Y(_J7X._X(
MY_\ !+CP'XDL?%OAO]A?]GB+7=,N$N]/N-7\"VGBBSL[N*>.Y@N[?1_%$FLZ
M-'=VL\4<MG=+IXGLY$#6LD)S7Z26]O;VEO!:6D$-K:VL,5O;6UO$D-O;V\*+
M'#!!#&JQQ0Q1JL<44:JD:*JHH4 5^#>L?\%X/AI#IOF:!^S_ ..M1U?RL_8M
M8\7Z!HNFB?8#L_M.RT[7[IHA)E?-_LE7* /Y09BB_G'^TA_P5F_:<^/-A?\
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MD6LG]GK?7.DF;QC#\.+[5;-]CRZ?)#I/Q$U&VN]0@VM'I5WJ%O,ZVES<FO\
M/P_X)A^/]#^&'_!1']BKQEXGT[2-4\+V7[2GPETKQ/;:[!'<Z5'X;\4^+],\
M*:_J-S;S@P3-I&D:W>:M;17 ^SO=64"S_N2]=7@SBJ-#PWSBM1P<<75P>89S
M5Q&$G448X^M#+<)6A1E*I&I"E"O0]CAFY4Y07+*<H2O+FSXUHSJ<38&$ZSHP
MKX?!0IUXP;>'A+%5J<II1<93E3GSUK*2E[RBI+2WTO\ \/\ ;_@K]_T>]\0O
M_"3^%'_S 4?\/]O^"OW_ $>]\0O_  D_A1_\P%?ZIG_"I/A3_P!$Q^'O_A%^
M&_\ Y6T?\*D^%/\ T3'X>_\ A%^&_P#Y6U^?_P#$6.#O^C3\/?\ @65^7_5.
M_P!67R^B_P!4LZ_Z+#,_NQ?E_P!3/^K+Y?Y6?_#_ &_X*_?]'O?$+_PD_A1_
M\P%'_#_;_@K]_P!'O?$+_P )/X4?_,!7^J9_PJ3X4_\ 1,?A[_X1?AO_ .5M
M'_"I/A3_ -$Q^'O_ (1?AO\ ^5M'_$6.#O\ HT_#W_@65^7_ %3O]67R/]4L
MZ_Z+#,_NQ?E_U,_ZLOE_DB?M#_\ !6;_ (*(?M7_  NU?X*_M"_M/>+_ (F_
M"[7K[1M3U?PAJ^@> M/L;Z^\/:E;ZQHUQ)<Z!X2TG4E:QU*UM[N-8KV.-Y(E
M69)(\H?.?^"<=W/8_P#!0O\ 8/OK9@EQ9_MF_LO74#E0X6:W^-_@>:)BC JP
M5T4E6!5@,$$&O]@'_A4GPI_Z)C\/?_"+\-__ "MJ>V^%OPQLKBWO+/X<^!+2
M[M)XKFUNK;PAX?@N+:X@D66"XMYXM/66&>&55DBEC99(Y%5T8, :[8^-^5X;
M+<9EF6<"83*L/C*6)A*G@<QP^&HJKB*"H2KRH8?):,*E104$V[2G&G"#FDER
MX/@7%5<50Q6+X@KXRI0G2:EB,+4JSY*53VBI*I4Q\Y1C=SLE=)R;Y;MG=U_F
MI_\ !V#_ ,I2],_[-?\ A'_ZDGQ)K_2LK_-3_P"#L'_E*7IG_9K_ ,(__4D^
M)-?.^!G_ "75/_L4YC_[A/2X[_Y)^I_V%8;_ -*D?I)_P9F?\Y(/^[/_ /WZ
M.O[B*_AW_P"#,S_G)!_W9_\ ^_1U_<17D^,/_)QN(O\ ND?^J++#JX,_Y)K+
M?^YS_P!3\4%%%%?F9]0?XKW[37_)R/[0?_9;_BO_ .IYK]?ZIG_!#[_E$S^P
MK_V1#3?_ $^:Y7^5G^TU_P G(_M!_P#9;_BO_P"IYK]?ZIG_  0^_P"43/["
MO_9$--_]/FN5_4'C?_R1O!__ &$4/_54?E? O_(ZSG_KW/\ ]2S]5:***_E\
M_5#\'?\ @Y;_ .4-W[47_8>_9_\ _6AOA?7^<K_P3O\ ^4@'[#/_ &>)^S+_
M .KJ\$U_HU?\'+?_ "AN_:B_[#W[/_\ ZT-\+Z_SE?\ @G?_ ,I /V&?^SQ/
MV9?_ %=7@FOZM\&O^3:\3?\ 8SSO_P!466'Y)QI_R5&5_P#8-@/_ %/Q)_LF
M5_FA_P#!UIK\NL?\%5)-.D60)X4_9O\ @_H$!=PZM%<7_C;Q06B4(IBC\[Q)
M,I1C(QE663>%D5$_TO*_SCO^#N#X:ZUX9_X**?"WXC2:8T7AKXG?LP^#X=.U
MA?LXAO\ Q)X'\<_$#2/$>FD($N#=Z3H]_P"#KJ>2=)$:UUFPC@NG\J6VL_S+
MP.J4X<>4(SE%2JY9F,*2DTG*HJ=.HXP3UE+V5.I)QCKR1E+X8L^JX[C)\/U6
MDVHXG#2FTFU&/.XIOLN:45=V5VENTG]I?\&:6B6,^O\ _!0WQ')$IU+2M(_9
M:T2TF*@NECX@O?V@K_4(U?JJRW'AK3&90,,84)QL&?[GZ_@$_P"#/+XQZ'X;
M_:-_:^^!=_>+;:U\6/A+\._B%H%O)YJKJ'_"FO$_B/2-5MH7'^CM=Q6GQ?2]
M2W?_ $E[2UOI[<>3:WA']_=>?XR4ZD/$3/93C*,:M/*:E)M-*=-9/@*3E%M>
M]%5:56%U=<T)*]TTM^"I1EPW@%%IN$L7&:3NXR>-Q$TGV?)*,K.VDD]FF%%%
M%?EY]4%9FMZ18^(-&U?0=3B\[3=;TR_TC4(<*?-L=2M9;*[CPZNG[R":1?G1
MUY^96&0=.O$?VEOC+H'[._[/'QP^._BB\%AH/P@^%/CSXB:A<;#*Y3PIX:U'
M6(;:W@4%[F\O;FUALK&TC5I;N\N(+:)6DE4'2E3J5JM*E1C*=6K4A3I0@G*4
MZDY*,(QBDVY2DTDDFVVDD*4HQC*4VHQBG*4I.T8Q2NVV]$DKMMZ)'^*[7^O?
M_P $>]5GUG_@EK^P/=W#7+20_LN_";2E-U:O9R^1H7ABST.U58I(H6>W6VTZ
M%;.Z"%+ZT$%[%+/'<)/)_D(5_L>?\$W_ (7Z[\%OV /V,/A7XIMS9^*?!/[,
MOP7T;Q18F02_8/$L?@+0Y_$&GB4*@D6PU>>\LU<* RP@C(Y/]3?2%J064<.T
MG)*K/,L74A"_O2ITL+"-226[495:2D]DYQONC\G\.8R>,S*:3Y(X:C&4NBE.
MK)Q3\VH3:_PL_E+_ .#S/_G&_P#]W@?^^N5^?_\ P:1?\I./B)_V9W\4O_5I
M_ ROT _X/,_^<;__ '>!_P"^N5^?_P#P:1?\I./B)_V9W\4O_5I_ RJR?_E'
MVM_V*\\_]:#,"<;_ ,G$A_V%X#_U7X8_TB****_E,_6PK_)Q_P""^W_*7[]M
M[_LH7A/_ -51X K_ %CJ_P G'_@OM_RE^_;>_P"RA>$__54> *_=/H__ /)7
MYI_V3>*_]6>4'P7B'_R)L)_V,Z7_ *BXP_KH_P"#0K_E&Q\;O^SXOB5_ZH7]
MFBOZIJ_E9_X-"O\ E&Q\;O\ L^+XE?\ JA?V:*_JFKX3Q+_Y+SB?_L9U/_3=
M,]_AC_DG\J_[!8_^E2"O#/VH/^3:?VA_^R&?%K_U ?$%>YUX9^U!_P FT_M#
M_P#9#/BU_P"H#X@KXNA_'H_]?:?_ *6CW7L_1_D?XL5?[3O[+_\ R;3^SQ_V
M0SX2_P#J ^'Z_P 6*O\ :=_9?_Y-I_9X_P"R&?"7_P!0'P_7]+_2)_A<)?\
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MV;3FM_AQX8U&(K(L]CHUYONO%-[:S#-KJGB&.WLAB*XA\-65]#'<K^P0
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M$&O7MQ<:K-?627%SX$U^:\U![&[\/:[JMWX:_M"_X*4?\$V/@+_P4R^ M_\
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MC]_ZM?Q97^E9_P &WG_*%W]C3_NXC_UJWXYU_FI_MO?\GH_M>?\ 9T'Q^_\
M5K^+*_TK/^#;S_E"[^QI_P!W$?\ K5OQSK^K?&C_ )-OPS_V-<E_]4.:GY)P
M3_R4V:?]@F._]6&$/U+_ &I/@+X>_:D_9O\ CG^SGXJN);'0OC7\+/&OPWN]
M4MUA:[T27Q3H-[I>G^(+$7-O=V_]H^']1GM-:TYI[6YA2^L+=Y+>9%,;?XV'
MQA^$WCSX#_%7XA_!?XGZ'<>&_B%\+O&&O^!_%^BW*2JUEKGAW49]-O?(>6*$
MW5A<20?:],U"-!;ZEIT]KJ%JTEM<PR-_MD5_(O\ \'&O_!$;Q+^U-#)^W!^R
M%X'CU[]H'0-.LK#XY?#+088+;6_C%X.T:P%EIGC;PW;_ +N/7/B7X+TZUL]*
MN]'=DU3QAX+M+:STB>\U_P +Z#X=\0_GG@QQMAN&\VQ.49I6AA\KSITN3$U9
M1A1P>84KQI3K5)N,:6'Q%.<J-6K)VA4AAY2Y:2J3C])QMD=7-,'2Q>$IRJ8O
M \]Z4(RE4KX>=G.%.,4W.I3DE.$5K*+J)7DXQ?ZP_P#!%/\ X*9>#?\ @I#^
MR#X0UZ^\0Z9_PT;\)M&T/P-^T3X,^UPIK4/B>PLA9:=\1X-,9ENCX4^)UM8R
MZ]IFH11/IUKKH\2>%8[NXO?#5ZU?L/7^,!^R]^U/^T'^Q!\;]"^./[/GCC6?
MAG\4/",EYI5RZP"6PUG2+B>%=<\%^-O#6H1OI_B'PWJ4MG -3T#6;66.&_L;
M#5+3[#KFD:7J-C_;)^Q]_P '=GP&\4:)X?\ #G[;?P-\:_"SQQB&PUGXC_!6
MVM_'GPNOI(=.ADN/$5YX3UC6-/\ B#X.MKW4%N[>'P]I!^*-Q9H;*5]9N(Y[
MK^S^KCSP<SG+\?B,QX6PD\UR;$RGB(83#.,\;E[FY3EAXT+J>+P\=L+/#JI6
MY&J56GS05:MED'&F"Q-"GA\UK1P>.II4Y5:MXT,1RVBJKJ/W:-1_\O8U'&"D
MG.$E%\D/[&Z*_!E/^#E[_@C@T*2-^TYXBC=HU<V[_ #]H S1L5#&%VC^&DD!
MD4_(Q2=X=P)65DPY_/S]K#_@[C_92\"Z/JNC_LA?![XB_';QLUIC2?%?Q%LT
M^%WPLL[N:1XUN+BTDNK_ .(FO"R1!<S:3_PC_A-+U9(K>'Q#:NTTMO\ GF#\
M/N-\=7AAZ/"V=TYS:2GC,OQ& H1NTKSQ.-AAZ$$KW?-46EWLF?1UN(LBH4Y5
M)YM@)1CJU1Q-/$5'I?W:5"52I)^48/73<_H3_;V_;Y_9^_X)T? 75OCY^T#K
M=U%I<5[;:)X1\$>'CIMSX^^)/B>[D3R_#?@?1M3U'2[?4K^WM#/JNJ7%S?6>
MF:/I%G=:AJ=]:PHAD[_]E+]L#]G3]MKX4:;\9OV:?B=X?^)7@N]:"TU/^R[I
M(]?\(:Y+8VNHR^%?'/AR9EU?PCXIL[2\M;BYT36K6UNC;7%M?6PN-/NK6[G_
M ,E?]L3]MW]JS_@H]\;;7XD_'_Q=JOQ"\9:A<IX>\ >!/#6GW=OX4\(VVKWE
MO#:>$?AIX'LI+W["-1O!90.(O[1\1^([V.SDUG4]9U!(IJ_O9_X-S?\ @D+X
M]_8 ^&'B[]H3]H.35=$_:"_:$\/:'IQ^%J:I<+IGPO\ AS97']M:9I?BK3+=
MUL+_ .)6K7\RWFL/<_;CX/L(H/#VF2V5]>^+!?\ VW%OAIE/!O"&&QF;YU;B
MO$5[T<OPZC5PN)IRE1C4PU.,E"LHX*GSUJN8/EI.I-8?V,G.A.7AY/Q/B\ZS
MBK1P>"_X2*5.T\34O"K3DE-PJ2LY0;KSM"&'UFH)U7-<LXK^F:O\U/\ X.P?
M^4I>F?\ 9K_PC_\ 4D^)-?Z5E?YJ?_!V#_RE+TS_ +-?^$?_ *DGQ)K+P,_Y
M+JG_ -BG,?\ W"7QW_R3]3_L*PW_ *5(_23_ (,S/^<D'_=G_P#[]'7]Q%?P
M[_\ !F9_SD@_[L__ /?HZ_N(KR?&'_DXW$7_ '2/_5%EAU<&?\DUEO\ W.?^
MI^*"BBBOS,^H/\5[]IK_ ).1_:#_ .RW_%?_ -3S7Z_U3/\ @A]_RB9_85_[
M(AIO_I\URO\ *S_::_Y.1_:#_P"RW_%?_P!3S7Z_U3/^"'W_ "B9_85_[(AI
MO_I\UROZ@\;_ /DC>#_^PBA_ZJC\KX%_Y'6<_P#7N?\ ZEGZJT445_+Y^J'X
M._\ !RW_ ,H;OVHO^P]^S_\ ^M#?"^O\Y7_@G?\ \I /V&?^SQ/V9?\ U=7@
MFO\ 1J_X.6_^4-W[47_8>_9__P#6AOA?7^<K_P $[_\ E(!^PS_V>)^S+_ZN
MKP37]6^#7_)M>)O^QGG?_JBRP_).-/\ DJ,K_P"P; ?^I^)/]DROYF?^#H[]
MAR__ &F?V$[#]H/P3I27_P 1OV-]8U?X@WT<-O&]_J/P5\2VEE8?%BUAE>XM
MEC3PY_9/ACXA74LIN?*T7P?KT%I:M=WZ&OZ9JJW]C9:I8WFF:E:6U_IVHVMQ
M8W]C>0QW-I>V5W"]O=6EU;S*\4]M<P220SPRHT<L3LCJRL0?YKX?SK$\.YUE
MN=817K9=BJ==4V^6-:GK"OAYRLW&&(H2J4)R2YE&HW'WDC]/S'!4LRP.)P-:
MZIXFE*FY)7<);TZB5TG*E44:D4]&XI/2Y_C5?L-?M:>-_P!AK]J[X+?M1^ 8
MS>:O\*_%L.HZIH;3/#;^*_!VJVMSH'CGPC=.K*$B\2^$M4UC28KEP_\ 9]W<
MVVI1HT]E#C_7@_9>_::^#_[8/P,\ ?M"_ OQ58^+?AY\0='@U*PN;::%K_1M
M1"*FL>%O$EE%)))HWBGPW?\ FZ5KVC7>RZL+Z"1'4QM%))_G5_\ !=3_ ((<
M_$#]@3XD>)OVA/@#X:UKQE^Q7X\U^[U:WN-*LFU"^_9UUO7+RZNV^'WC&&R5
M[F/X?PS$VOP^\>W4"626;Z?X,\5WW_"50Z7JWC3\XO\ @G;_ ,%4/VL_^"9W
MCJ\\1_ 'Q7:ZAX'\27MI=?$#X,>-H[S5_AGXW^S^1$U[<Z5;WEG=Z#XF6R@2
MSM?%OAV\TW6H[>.WM+V;4=+A_LU_Z@XSX5R[Q8R3+^)^%L70>:T,/[%4ZLHP
M5>ES.I4RW&NSEA<;A*LZCHRFO9R]I-2;H5J.(I_EF29MB>$<;B,JS:C46#J5
M7/VD8N3A.RBL31Z5J%6$8^TC'WXV37[R$Z4O]?"BOY1/V<?^#MW]AKX@Z?86
M/[1OPI^,_P"SSXK_ +.\_4]0T?3M.^+_ ,-_MT4L$$EII^M>'Y]'\>F6Z65K
MVVCN?ALMI#;V]U;W&JFY2S&H?2OBO_@Z0_X))^'M"U#5M'^(GQ@\>:A9VLL]
MMX8\+?!/Q=9:UJLR6\DR65C<^-E\'^'(KB:5%M$?4]?T^T6>5'EN8[427$?\
M[U_#WCC#UWAJG"V=RJ*2CS4,#6Q5"[?+=8K#1JX9QOO)5N5+WFU'4_1J?$61
M5:?M8YM@%&U[5,13I5+6O_"JN%6_ER7OI:Y_1-7\4O\ P=,_\%5M!L/!Q_X)
MK? WQ-8ZMXD\27NEZ]^U1KFB:I)(WA/0]&NM/UWPA\()'LU-N^L^)=3CL_%'
MC.U>]BN=%T;1=#T:]L;J/Q;?IIWQM_P4&_X.N_CE\:= UCX:_L,_#^__ &;/
M"VKVXL]0^,'C2XT?Q%\;)[222)[F'POI5B=1\%?#V2Y@6;3[C4Q<^-M<2WN6
MO- U7PSJT%K?P?S!?!WX+?'O]KOXR:;\-/@_X-\9_&KXT?$?6;N]33=/>35M
M=UK4M0NS<ZOXB\2:]J]U%::?9_:[MK[Q#XM\4:K8Z79&>74-:U6WC:2>OV+P
MY\)\5E6,H\4\9_5LOPV67QF%R_$5Z5X5J2YZ>.S&LI_5\-0PKM6ITG5<Y5H1
MEB52ITW3K_&<2\74L51GE.2>TQ-7%KV-7$4J<VG"I[LJ&&AR^TJU:JO3E)04
M8PDU2<YRYJ?V?_P1[_87UO\ X* _MY_!;X-G1WOOAAX>U^R^)WQWU&:R6\TG
M3?A'X'OK35=?TK4E:[LBK^/KM-.^'&EM UU/:ZGXMMM4DL+K3=,U'R_]<Z.-
M(HTBB1(XHT6...-0D<<: *B(B@*B(H"JJ@*H    K\>O^",G_!*7P;_P2Z_9
MP_X1S47TCQ/^T=\5$T;Q#\?OB#IW^E64NL6-HZZ9\/O!U_/8:=?MX!\$O>:B
MNERWEK;WFN:QJ.L^(;R"S74++2=*_8BOSCQ3XTAQCQ#S8*3>4953G@\N;5G7
M<IJ6*QK3NU]9J1A&FM/]FH4)2A"I*HG]+PIDCR7+>6M_OF+E&OB;:JG[MJ5!
M.RO[*+;GO^]G4M*4%$_AW_X/,_\ G&__ -W@?^^N5^?_ /P:1?\ *3CXB?\
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M? -?XZ-?[%W_  3&_P"4;'_!/7_LQW]DW_U0O@&O3^D)_P B;A[_ +&>*_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDY)S@VXRAS6CS\LE_J\T445_'A^RA1110 4444 %%%% !1110 4444 %%%%
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MJ59+FV_AR>N@L95J4J=-TY0C*I7HTN:I%RC%5)<K;BIPO;_$O4^DO@Q^V[\
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M^$?[-?\ PBG_  M/4M8T[_A-/[=_L+^RM#O=9\[_ (1S^QO[4\_[(#]F\O\
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MHH **** "BBB@ HHHH **** "BBB@#Y?_;4_Y-2^/'_9/=8_]HT?L5_\FI?
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ML1B*V'E/#O#PP]256;G4ISE.;I3IJ%-4I2]W]XY.<^5V22C=Z>X5\\?M;_\
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=K&4DUS>V<I4TZ<Z7*Z4F^;FMHONVBBBOF3U#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
